Extrahepatic manifestations in transgenic mice of osteopontin in hepatocytes - A clue to advent of pathological state in various organs of chronic hepatitis C patients

Hepatology Research

Volumn 31, Issue 4, 2005, Pages 197-202

  Eiko, Saitoh ^a   Matsui, Atsushi ^a   Inao, Mie ^a   Mimura, Sumie ^a   Koh, HeaSaeng ^a   Ohno, Akihiko ^a   Nagoshi, Sumiko ^a   Kayano, Hidekazu ^a   Yoshimoto, Takayuki ^b   Mochida, Satoshi ^a   Fujiwara, Kenji ^a  

^a SAITAMA MEDICAL UNIVERSITY   (Japan)

^b TOKYO MEDICAL UNIVERSITY   (Japan)

Author keywords

Interstisial pneumonia; Lymphoadenopathy; Osteopontin; Salivary glands; Splenomegaly; Transgenic mouse

Indexed keywords

CD20 ANTIGEN; CD3 ANTIGEN; OSTEOPONTIN; VIRUS PROTEIN;

ANIMAL TISSUE; ARTICLE; B LYMPHOCYTE; CELLULAR IMMUNITY; CONTROLLED STUDY; FEMALE; HEPATITIS C; HEPATITIS C VIRUS; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; INTERSTITIAL PNEUMONIA; LIVER CELL; LIVER NECROSIS; LUNG INFILTRATE; LYMPHADENITIS; LYMPHOCYTIC INFILTRATION; MALE; MOUSE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; SPLENOMEGALY; T LYMPHOCYTE; TH1 CELL; TRANSGENIC MOUSE; UPREGULATION;

EID: 21144455335     PISSN: 13866346     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.hepres.2005.01.010     Document Type: Article

References (34)

1. J.M. Barrera M. Bruguera M.G. Ercilla et al. Persistent hepatitis C viremia after acute self-limiting posttransfusion hepatitis C Hepatology 21 1995 639-644
2. E. Tanaka K. Kiyosawa Natural history of acute hepatitis C J Gastroenterol Hepatol 15 2000 E97-E104
3. A. Cerny F.V. Chisari Pathogenesis of chronic hepatitis C: Immunological features of hepatic injury and viral persistence Hepatology 30 1999 595-601
4. K. Ando K. Hiroishi T. Kaneko et al. Perforin, Fas/Fas ligand, and TNF-α pathways as specific and bystander killing mechanisms of hepatitis C virus-specific human CTL J Immunol 158 1997 5283-5291
5. P. Cacoub T. Poynard P. Ghillani et al. Extrahepatic manifestations of chronic hepatitis C. MULTIVIRC Group Multidepartment Virus C Arthritis Rheum 42 1999 2204-2212
6. Y. Nagao J. Tanaka T. Nakanishi et al. High incidence of extrahepatic manifestations in an HCV hyperendemic area Hepatol Res 22 2002 27-36
7. D.H. Van Thiel S. Fagiuoli P. Caraceni et al. Cryoglobulinemia: A cause for false negative polymerase chain reaction results in patients with hepatitis C virus positive chronic liver disease J Hepatol 22 1995 464-467
8. R.J. Johnson D.R. Getch H. Yamabe et al. Membranoproliferative glomerulonephritis associated with hepatitis C virus infection N Engl J Med 328 1993 465-470
9. J. Haddad P. Deny C. Munz-Gotheil et al. Lymphocytic sialadenitis of Sjögren's syndrome associated with chronic hepatitis C virus liver disease Lancet 339 1992 321-323
10. T. Izumi R. Sasaki Y. Miura H. Okamoto Promary hepatosplenic lymphoma: association with hepatitis C virus infection Blood 87 1996 5380-5381
11. Y. Nagao M. Sata K. Fukuzumi K. Tanikawa T. Kameyama High incidence of oral precancerous lesions in a hyperendemic area of hepatitis C virus infection Hepatol Res 8 1997 173-177
12. T. Ueda K. Ohta N. Suzuki et al. Idiopathic pulmonary fibrosis and high prevalence of serum antibodies to hepatitis C virus Am Rev Respir Dis 146 1992 266-268
13. Y. Nagao M. Sata K. Aba K. Tanikawa T. Kameyama Immunological evaluation in oral lichen planus with chronic hepatitis C J Gastroenterol 32 1997 324-329
14. T. Laskus M. Radkowski L.F. Wang H. Vargas J. Rakela Search for hepatitis C virus extrahepatic replication sites in patients with acquired immunodeficiency syndrome: Specific detection of negative-strand viral RNA in various tissues Hepatology 28 1998 1398-1401
15. W.T. Butler The nature and significance of osteopontin Connect Tissue Res 23 1989 123-136
16. T. Uede Y. Katagiri J. Iizuka M. Murakami Osteopontin, a coordinator of host defense system: A cytokine or an extracellular adhesive protein? Microbiol Immunol 41 1997 641-648
17. R.P. Singh R. Patarca J. Schwartz P. Singh H. Cantor Definition of a specific interaction between the early T lymphocyte activation 1 (Eta-1) protein and murine macrophages in vitro and its effect upon macrophages in vivo J Exp Med 71 1990 1931-1942
18. C.E. Murry C.M. Giachelli S.M. Schwartz R. Vracko Macrophages express osteopontin during repair of myocardial necrosis Am J Pathol 145 1994 1450-1462
19. S. Ashkar G.F. Weber V. Panoutsakopoulou et al. Eta-1 (osteopontin): An early component of type-1 (cell-mediated) immunity Science 287 2000 860-864
20. S. Mochida T. Yoshimoto S. Mimura et al. Transgenic mice expressing osteopontin in hepatocytes as a model of autoimmune hepatitis Biochem Biophys Res Commun 317 2004 114-1120
21. F. Silvaestri C. Pipan G. Barillari et al. Prevalence of hepatitis C virus infection in patients with lymphoproliferative disorders Blood 87 1996 4296-4301
22. F. Franzin D.G. Efremov G. Pozzato P. Tulissi F. Batista O.R. Burrone Clonal B-cell expansions in peripheral blood of HCV infected patients Br J Haematol 90 1995 548-552
23. S. De Vita C. Sacco D. Sansonno et al. Characterization of overt B-cell lymphomas in patients with hepatitis C virus in patients with hepatitis C virus infection Blood 90 1997 776-782
24. C. Ferri L. La Civita M. Monti et al. Can hepatitis C virus infection be complicated by malignant lymphoma? Lancet 346 1995 1426-1427
25. S. De Vita D. Sansonno R. Dolcetti et al. Hepatitis C virus within a malignant lymphoma lesion in the course of type II mixed cryoglobulinemia Blood 86 1995 1887-1892
26. K. Koike K. Moriya K. Ishibashi et al. Sialadenitis histologically resembling Sjögren syndrome in mice transgenic for hepatitis C virus envelope genes Proc Natl Acad Sci USA 94 1997 233-236
27. S. Ohoka Y. Tanaka Y. Amako et al. Siladenitis in patients with chronic hepatitis C is not directly related to hepatitis C virus Hepatol Res 27 2003 23-29
28. A. Matsui S. Mochida A. Ohno S. Nagoshi T. Hirose K. Fujiwara Plasma osteopontin levels in patients with fulminant hepatitis Hepatol Res 29 2004 202-206
29. Y. Arase K. Ikeda A. Tsubota et al. Serum levels of γ-globulin and total bilirubin influence the prevalence of multiple extrahepatic complication in patients with hepatitis C virus infection Hepatol Res 25 2003 14-21
30. R.I. Fox Sjogren's syndrome: Immunobiology of exocrine gland dysfunction Adv Dent Res 10 1996 35-40
31. T. Okanoue S. Sakamoto Y. Itoh et al. Side effects of high-dose interferon therapy for chronic hepatitis C J Hepatol 25 1996 283-291
32. T. Ishizaki F. Sasaki S. Ameshima et al. Pneumonitis during interferon and/or herbal drug therapy in patients with chronic active hepatitis Eur Respir J 9 1996 2691-2696
33. T.V. Cacciarelli O.M. Martinez R.G. Gish J.C. Villanueva S.M. Krams Immunoregulatory cytokines in chronic hepatitis C virus infection: Pre- and posttreatment with interferon alfa Hepatology 24 1996 6-9
34. N. Ohtake R. Suzuki H. Daikuhara et al. Modulation of lung local immune responses by oral administration of a herbal medicine Sho-saiko-to Int J Immunopharmacol 22 2000 419-430